LCOR and nonpapillary renal cell carcinoma: Our study unveiled a potential molecular mechanism for the development of ccRCC, demonstrating that LCOR could interact with RUNX1 to relieve RUNX1-repressed PLCL1 transcription, leading to the upregulation of PLCL1 expression, which inhibited the tumor progression and lipid accumulation in ccRCC.